Literature DB >> 1574442

Tea consumption and cancer risk.

C La Vecchia1, E Negri, S Franceschi, B D'Avanzo, P Boyle.   

Abstract

The relationship between tea consumption and cancer risk has been analyzed using data from an integrated series of case-control studies conducted in northern Italy between 1983 and 1990. The dataset included 119 histologically confirmed cancers of the oral cavity and pharynx, 294 of the esophagus, 564 of the stomach, 673 of the colon, 406 of the rectum, 258 of the liver, 41 of the gallbladder, 303 of the pancreas, 149 of the larynx, 2,860 of the breast, 567 of the endometrium, 742 of the ovary, 107 of the prostate, 365 of the bladder, 147 of the kidney, 120 of the thyroid, and a total of 6,147 controls admitted to hospital for acute nonneoplastic conditions unrelated to long-term dietary modifications. Multivariate relative risks (RR) for tea consumption were derived after allowance for age, sex, area of residence, education, smoking, and coffee consumption. All the estimates for tea consumption were close to unity, the highest values being 1.4 for rectum, gallbladder, and endometrium. There was no association with cancers of the oral cavity (RR = 0.6), esophagus (RR = 1.0), stomach (RR = 1.0), bladder (RR = 0.8), kidney (RR = 1.1), prostate (RR = 0.9), or any other site considered. Although in northern Italy tea was consumed daily by only a limited proportion of the population, this integrated series of studies offers further reassuring evidence on the relationship between tea and cancer risk.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1574442     DOI: 10.1080/01635589209514170

Source DB:  PubMed          Journal:  Nutr Cancer        ISSN: 0163-5581            Impact factor:   2.900


  27 in total

Review 1.  Nutrition and esophageal cancer.

Authors:  K K Cheng; N E Day
Journal:  Cancer Causes Control       Date:  1996-01       Impact factor: 2.506

Review 2.  Tea and cancer prevention: epidemiological studies.

Authors:  Jian-Min Yuan; Canlan Sun; Lesley M Butler
Journal:  Pharmacol Res       Date:  2011-03-23       Impact factor: 7.658

3.  The association of tea consumption and the risk and progression of prostate cancer: a meta-analysis.

Authors:  Xiawei Fei; Yanting Shen; Xiaogong Li; Hongqian Guo
Journal:  Int J Clin Exp Med       Date:  2014-11-15

4.  Association between tea and coffee consumption and risk of laryngeal cancer: a meta-analysis.

Authors:  Zhiguo Ouyang; Zhaoyan Wang; Jian Jin
Journal:  Int J Clin Exp Med       Date:  2014-12-15

5.  Green tea and liver cancer.

Authors:  Francesca Bravi; Carlo La Vecchia; Federica Turati
Journal:  Hepatobiliary Surg Nutr       Date:  2017-04       Impact factor: 7.293

6.  Prospective cohort study of tea consumption and risk of digestive system cancers: results from the Shanghai Women's Health Study.

Authors:  Sarah Nechuta; Xiao-Ou Shu; Hong-Lan Li; Gong Yang; Bu-Tian Ji; Yong-Bing Xiang; Hui Cai; Wong-Ho Chow; Yu-Tang Gao; Wei Zheng
Journal:  Am J Clin Nutr       Date:  2012-10-10       Impact factor: 7.045

7.  Association between coffee or tea drinking and Barrett's esophagus or esophagitis: an Italian study.

Authors:  R A Filiberti; V Fontana; A De Ceglie; S Blanchi; E Grossi; D Della Casa; T Lacchin; M De Matthaeis; O Ignomirelli; R Cappiello; A Rosa; M Foti; F Laterza; V D'Onofrio; G Iaquinto; M Conio
Journal:  Eur J Clin Nutr       Date:  2017-05-10       Impact factor: 4.016

8.  Tea, coffee, carbonated soft drinks and upper gastrointestinal tract cancer risk in a large United States prospective cohort study.

Authors:  J S Ren; N D Freedman; F Kamangar; S M Dawsey; A R Hollenbeck; A Schatzkin; C C Abnet
Journal:  Eur J Cancer       Date:  2010-04-13       Impact factor: 9.162

9.  Green-tea consumption and risk of stomach cancer: a population-based case-control study in Shanghai, China.

Authors:  G P Yu; C C Hsieh; L Y Wang; S Z Yu; X L Li; T H Jin
Journal:  Cancer Causes Control       Date:  1995-11       Impact factor: 2.506

10.  Tea consumption and risk of gallbladder cancer: A meta-analysis of epidemiological studies.

Authors:  Guangwei Zhu; Jin Hua; Zhijian Wang; Feifei She; Yanling Chen
Journal:  Mol Clin Oncol       Date:  2015-01-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.